Pressure BioSciences is a company engaged in the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on pressure cycling technology (PCT). A patented, enabling technology platform, PCT has multiple applications within the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions.
The company is currently focusing its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for forensics, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, histology, and counter-bioterror applications.
Since the company began operating as Pressure BioSciences in 2005, its research has been focused chiefly on research and development and commercialization efforts on sample preparation for genomic, proteomic, and small-molecule studies. The company’s business strategy is commercializing PCT in the area of sample preparation for genomic, proteomic, and small-molecule studies, and Pressure BioSciences also plans to pursue the further development and commercialization of PCT in other life sciences applications.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment